Vera Therapeutics Inc.
(VERA)
undefined
undefined%
At close: undefined
43.22
0.16%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 1.86M | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | -846.00K | 176.00K | 251.00K | 509.00K |
| Gross Profit | 1.86M | 846.00K | -176.00K | -251.00K | -509.00K |
| Operating Income | -102.01M | -90.90M | -34.40M | -52.24M | -11.96M |
| Interest Income | 4.19M | 1.75M | 15.00K | 8.00K | 159.00K |
| Pretax Income | -95.99M | -89.06M | -32.61M | -53.41M | -11.85M |
| Net Income | -95.99M | -89.06M | -32.61M | -53.41M | -11.85M |
| Selling & General & Admin | 23.79M | 21.91M | 11.92M | 4.04M | 4.41M |
| Research & Development | 78.22M | 68.99M | 22.48M | 45.21M | 7.29M |
| Other Expenses | n/a | 1.85M | 1.79M | -1.08M | n/a |
| Operating Expenses | 102.01M | 90.90M | 34.40M | 49.24M | 11.70M |
| Interest Expense | n/a | 992.00K | 20.00K | 166.00K | 51.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 102.01M | 90.90M | 34.40M | 49.24M | 11.70M |
| Income Tax | 1K | 1K | 1K | 1K | 1K |
| Shares Outstanding (Basic) | 42.71M | 26.57M | 21.28M | 3.71M | 3.42M |
| Shares Outstanding (Diluted) | 42.71M | 26.57M | 21.28M | 3.71M | 3.42M |
| EPS (Basic) | -2.25 | -3.35 | -1.53 | -14.4 | -3.46 |
| EPS (Diluted) | -2.25 | -3.35 | -1.53 | -14.4 | -3.46 |
| EBITDA | -102.01M | -90.90M | -34.23M | -52.99M | -11.19M |
| Depreciation & Amortization | n/a | -846.00K | 176.00K | 251.00K | 509.00K |